March 15, 2023 Critical Path for Rare Neurodegenerative Diseases (CP-RND): An Introduction to the Patient Community Thank you for your interest in the recent webinar, Critical Path for Rare Neurodegenerative Diseases (CP-RND): An Introduction...
April 20, 2023 CRDSA Secondary Use Data Sharing Webinar Please join the Clinical Research Data Sharing Alliance on Thursday, April 20, for “Secondary Use Data: What do R
Rare Disease COA Consortium Announces Publication of Open Access Article C-Path’s Rare Disease COA Consortium is pleased to announce that “Approaches to the Assessment of Clinical Benefit of Treatmen
April 24, 2023 Leveraging Biolink as a “Rosetta Stone” Between C-Path and EJP-RD Semantic Models Provides Emergent Interoperability
March 8, 2023 Establishing a Basis for Secondary Use Standards for Clinical Trials Study seeks to understand how different forms of data meet the needs of researchers.
April 25, 2023 Approaches to the Assessment of Clinical Benefit of Treatments for Conditions That Have Heterogeneous Symptoms and Impacts Evaluating the clinical benefit of interventions aimed at treating conditions with heterogeneous symptom....
June 8, 2023 View Now: GUIDs and De-Identification Tools for Rare Diseases C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform is pleased to present this new webinar, GUIDs and De-Identi
April 26, 2023 C-Path Europe: A Global Vision of Success TUCSON, Ariz. and AMSTERDAM, April 26, 2023 — As an organization that generates regulatory-endorsed solutions and methodologies